MIRANDA PIERCE: Open Payments
NPI 1073230769 · LOMPOC, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 13 payments from 9 companies in 2025. Trend: 2023 $160 · 2024 $224 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $152 |
| Lilly USA, LLC | 2 | $51 |
| PFIZER INC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Exact Sciences Corporation | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $12 |
Products named: Ozempic, MOUNJARO, PREVNAR 20, FARXIGA, Wegovy, JARDIANCE, SHINGRIX, Miro3D.
Industry payments across CA — which companies pay providers there.
